These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 6128002

  • 1. Striatal synaptosomal tyrosine hydroxylase activity. A model system for study of presynaptic dopamine receptors.
    McMillen BA.
    Biochem Pharmacol; 1982 Aug 15; 31(16):2643-7. PubMed ID: 6128002
    [Abstract] [Full Text] [Related]

  • 2. Dopamine autoreceptor regulation of the kinetic state of striatal tyrosine hydroxylase.
    Strait KA, Kuczenski R.
    Mol Pharmacol; 1986 Jun 15; 29(6):561-9. PubMed ID: 2872588
    [Abstract] [Full Text] [Related]

  • 3. Is inhibition of striatal synaptosomal tyrosine hydroxylation by dopamine agonists a measure of dopamine autoreceptor function?
    Fowler CJ, Thorell G, Andersson M, Magnusson O.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Oct 15; 331(1):12-9. PubMed ID: 2866447
    [Abstract] [Full Text] [Related]

  • 4. Presynaptic dopamine and serotonin receptors modulating tyrosine hydroxylase activity in synaptosomes of the nucleus accumbens of rats.
    Hetey L, Kudrin VS, Shemanow AY, Rayevsky KS, Oelssner W.
    Eur J Pharmacol; 1985 Jul 11; 113(1):1-10. PubMed ID: 2864259
    [Abstract] [Full Text] [Related]

  • 5. The effect of butaclamol and of other neuroleptic agents on the apomorphine-elicited inhibition of synaptosomal tyrosine hydroxylase activity.
    Bronaugh RL, Tabak J, Ohashi T, Goldstein M.
    Psychopharmacol Commun; 1975 Jul 11; 1(5):501-10. PubMed ID: 7003
    [Abstract] [Full Text] [Related]

  • 6. Effects of pertussis toxin on inhibition of synaptosomal tyrosine hydroxylase activity by apomorphine.
    Harada K, Meller E, Goldstein M.
    Eur J Pharmacol; 1990 Mar 13; 188(2-3):123-8. PubMed ID: 1969353
    [Abstract] [Full Text] [Related]

  • 7. Presynaptic dopamine autoreceptors control tyrosine hydroxylase activation in depolarized striatal dopaminergic terminals.
    el Mestikawy S, Glowinski J, Hamon M.
    J Neurochem; 1986 Jan 13; 46(1):12-22. PubMed ID: 2866232
    [Abstract] [Full Text] [Related]

  • 8. Antagonistic effects of apomorphine and haloperidol on rat striatal synaptosomal tyrosine hydroxylase.
    Christiansen J, Squires RF.
    J Pharm Pharmacol; 1974 May 13; 26(5):367-9. PubMed ID: 4152779
    [No Abstract] [Full Text] [Related]

  • 9. [Effect of the atypical neuroleptics karbidin and sulpiride on the synaptosomal tyrosine hydroxylase of the corpus striatum of rats].
    Meos AA, Kudrin VS, Raevskiĭ KS.
    Biull Eksp Biol Med; 1984 Sep 13; 98(9):305-8. PubMed ID: 6148973
    [Abstract] [Full Text] [Related]

  • 10. Dopaminergic neurons: an in vivo system for measuring drug interactions with presynaptic receptors.
    Walters JR, Roth RH.
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Dec 13; 296(1):5-14. PubMed ID: 13315
    [Abstract] [Full Text] [Related]

  • 11. Adenosine A2 stimulation of tyrosine hydroxylase in rat striatal minces is reversed by dopamine D2 autoreceptor activation.
    Booth RG, Baldessarini RJ.
    Eur J Pharmacol; 1990 Aug 28; 185(2-3):217-21. PubMed ID: 1979274
    [Abstract] [Full Text] [Related]

  • 12. Evidence that adenosine A2 and dopamine autoreceptors antagonistically regulate tyrosine hydroxylase activity in rat striatal synaptosomes.
    Onali P, Olianas MC, Bunse B.
    Brain Res; 1988 Jul 26; 456(2):302-9. PubMed ID: 2905190
    [Abstract] [Full Text] [Related]

  • 13. The effect of various chlorpromazine derivatives on the apomorphine-elicited inhibition of synaptosomal tyrosine hydroxylase activity.
    Bronaugh RL, Goldstein M.
    Psychopharmacol Commun; 1975 Jul 26; 1(2):201-8. PubMed ID: 4859
    [Abstract] [Full Text] [Related]

  • 14. Is dopamine-induced inhibition of adenylate cyclase involved in the autoreceptor-mediated negative control of tyrosine hydroxylase in striatal dopaminergic terminals?
    el Mestikawy S, Hamon M.
    J Neurochem; 1986 Nov 26; 47(5):1425-33. PubMed ID: 2876053
    [Abstract] [Full Text] [Related]

  • 15. Dopamine synthesis in synaptosomes: relation of autoreceptor functioning to pH, membrane depolarization, and intrasynaptosomal dopamine content.
    Saller CF, Salama AI.
    J Neurochem; 1984 Sep 26; 43(3):675-88. PubMed ID: 6747629
    [Abstract] [Full Text] [Related]

  • 16. Dopamine autoreceptor stimulation increases protein carboxyl methylation in striatal slices.
    Wolf ME, Roth RH.
    J Neurochem; 1985 Jan 26; 44(1):291-8. PubMed ID: 3964833
    [Abstract] [Full Text] [Related]

  • 17. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
    Booth RG, Baldessarini RJ, Kula NS, Gao Y, Zong R, Neumeyer JL.
    Mol Pharmacol; 1990 Jul 26; 38(1):92-101. PubMed ID: 1973525
    [Abstract] [Full Text] [Related]

  • 18. Pre- and postsynaptic neurochemical alterations following estrogen-induced striatal dopamine hypo- and hypersensitivity.
    Gordon JH, Perry KO.
    Brain Res Bull; 1983 Apr 26; 10(4):425-8. PubMed ID: 6134572
    [Abstract] [Full Text] [Related]

  • 19. Dopamine receptor antagonism by the novel antianxiety drug, buspirone.
    McMillen BA, Matthews RT, Sanghera MK, Shepard PD, German DC.
    J Neurosci; 1983 Apr 26; 3(4):733-8. PubMed ID: 6131948
    [No Abstract] [Full Text] [Related]

  • 20. The effect of dopamine and of apomorphine on dB-cAMP induced stimulation of synaptosomal tyrosine hydroxylase.
    Ebstein B, Roberge C, Tabachnick J, Goldstein M.
    J Pharm Pharmacol; 1974 Dec 26; 26(12):975-7. PubMed ID: 4156865
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.